ANI Pharmaceuticals Files 8-K
Ticker: ANIP · Form: 8-K · Filed: Mar 18, 2025 · CIK: 1023024
| Field | Detail |
|---|---|
| Company | Ani Pharmaceuticals Inc (ANIP) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
ANI Pharma filed a routine 8-K, no major news.
AI Summary
ANI Pharmaceuticals, Inc. filed an 8-K on March 18, 2025, reporting other events and financial statements. The filing does not contain specific financial details or significant corporate actions beyond routine reporting requirements.
Why It Matters
This filing indicates routine corporate reporting by ANI Pharmaceuticals, Inc. to the SEC, without disclosing specific material events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for other events and financial statements, with no indication of significant risks or material changes.
Key Numbers
- 001-31812 — SEC File Number (Identifier for ANI Pharmaceuticals, Inc.)
- 58-2301143 — IRS Employer Identification No. (Tax identification for ANI Pharmaceuticals, Inc.)
Key Players & Entities
- ANI PHARMACEUTICALS INC (company) — Registrant
- 210 Main Street West (address) — Principal executive offices
- BAUDETTE (city) — Principal executive offices
- MN (state) — Principal executive offices
- 56623 (zip_code) — Principal executive offices
- BIOSANTE PHARMACEUTICALS INC (company) — Former company name
- BEN ABRAHAM TECHNOLOGIES INC (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of March 18, 2025.
What is the principal executive office address for ANI Pharmaceuticals, Inc.?
The principal executive office is located at 210 Main Street West, Baudette, Minnesota, 56623.
Has ANI Pharmaceuticals, Inc. had previous names?
Yes, the company was formerly known as BIOSANTE PHARMACEUTICALS INC and BEN ABRAHAM TECHNOLOGIES INC.
What is the SEC file number for ANI Pharmaceuticals, Inc.?
The SEC file number for ANI Pharmaceuticals, Inc. is 001-31812.
What is the fiscal year end for ANI Pharmaceuticals, Inc.?
The fiscal year end for ANI Pharmaceuticals, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding ANI PHARMACEUTICALS INC (ANIP).